IBM: Yorkville Ives initiates coverage with outperform rating; target price $275.00
IBM•Yorkville Ives initiated coverage of IBM with an outperform rating and a $275.00 target price.
Related News
Truist Securities raises Revolution Medicines target price to $240 from $239
RVMD•
OR Royalties Q3 2026 revenue rises 26% to $90.2 million; cash margin climbs 26% to $87.29 million
OR•
Zscaler: Wedbush raises target price to $240 from $215
ZS•
North American Construction Group target price cut to C$22 from C$24
NOA•
Albemarle: Argus Research cuts target price to $135 from $230
ALB•